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Abstract 
 
Objectives: The objectives of this study were to 1) document the incidence of 
surgical site dehiscence after full-thickness gastrointestinal biopsy in dogs and 
cats and 2) identify potential risk factors. 
 
Methods: Data relating to dogs and cats undergoing full-thickness 
gastrointestinal biopsy were reviewed retrospectively following submission of a 
completed questionnaire by 12 referral institutions. Outcome measures were 
definite dehiscence, possible dehiscence (clinical records suggestive of 
dehiscence but not confirmed), suspected dehiscence (definite and possible 
combined) and death within 14 days. Logistic regression was planned for 
analysis of association of dehiscence with low pre-operative serum albumin, 
biopsy through neoplastic tissue, biopsy alongside another major abdominal 
surgical procedure and biopsy of the colon. 
Results: Of one hundred and seventy two cats, 2 (1.2%) had definite dehiscence 
and 4 (2.3%) had possible dehiscence. Low pre-operative serum albumin was 
significantly associated with definite dehiscence in univariable analysis, and with 
suspected dehiscence and death within 14 days in univariable analysis, but all 
odds ratios had wide 95% confidence intervals. A histopathological diagnosis of 
neoplasia was significantly associated with death within 14 days in univariable 
analysis. 
Of one hundred and ninety-five dogs, 2 (1.0%) had definite dehiscence and 3 
(1.5%) had possible dehiscence. There was no association between any outcome 
measure and the putative risk factors. 
 
Clinical significance: This study reports a low incidence of dehiscence following 
full-thickness gastrointestinal biopsy. This information may aid decision making 
when determining the appropriateness of such a biopsy in individual cases but 
only when considered alongside the potentially life-threatening consequences of 
dehiscence. 
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Introduction 
 
Gastrointestinal biopsies are commonly performed as part of the diagnostic 
investigation of chronic gastrointestinal disease in small animal veterinary 
medicine.  Chronic enteropathies of the dog and cat typically have non-specific 
clinical presentations and imaging findings (Hall and Day 2017). It is therefore 
often necessary to obtain a tissue sample for histopathological analysis in order 
to reach a definitive diagnosis and subsequently provide an appropriate 
treatment plan and prognosis. Gastrointestinal biopsies can either be obtained 
endoscopically or surgically and there are specific advantages and limitations 
associated with each of these techniques (Hall 1994). Whilst obtaining an 
endoscopic gastrointestinal biopsy is a minimally invasive procedure with rapid 
recovery times, there are limitations to the size, depth and location of the biopsy 
sample that can be obtained via this method, tissue quality can vary and patient 
preparation is required (Hall 1994, Willard and others 2001, Jergens and others 
2016). A full-thickness surgical gastrointestinal biopsy provides a sample 
consisting of all layers of the gastrointestinal tract for analysis and can be 
obtained from any location along the tract. There are however prolonged 
recovery times associated with surgery and potential morbidities that are highly 
unlikely to be encountered with the endoscopic technique. The most significant 
morbidity associated with full-thickness incision of the gastrointestinal tract is 
the potential for post-operative intestinal dehiscence and ensuing septic 
peritonitis (Allen and others 1992, Wylie and Hosgood 1994). Mortality rates of 
approximately 50% are consistently reported in dogs and cats with septic 
peritonitis that are managed appropriately with prompt surgical intervention 
(King 1994, Lanz and others 2001, Parsons and others 2009). The high likelihood 
of a fatal outcome, if dehiscence of a surgical biopsy site were to occur, 
necessitates careful case selection along with appropriate pre-operative 
discussion with the client in order to obtain informed consent in light of the 
potential risks. 
 
Reported complication rates following intestinal surgery differs for dogs and 
cats. In the cat, a study investigating the prevalence of histological abnormalities 
in 300 cats undergoing full-thickness surgical gastrointestinal biopsies for the 
investigation of suspected chronic small bowel disease reported a full recovery 
in all cats with no surgical site dehiscence (Norsworthy and others 2015). In 
another study evaluating dehiscence in 70 cats with alimentary lymphoma 
undergoing full thickness gastrointestinal surgery, 11 of which were considered 
hypoalbuminaemic pre-operatively, none of the cats experienced post-operative 
dehiscence and consequently risk factors for dehiscence could not be identified 
(Smith and others 2011). In contrast, the incidence of dehiscence following 
gastrointestinal surgery in dogs has been reported to be 12% following small 
intestinal biopsy (Shales and others 2005) and 6% -15% following small 
intestinal enterotomy or anastomosis (Allen and others 1992, Wylie and 
Hosgood 1994, Ralphs and others 2003, Mouat and others 2014). A recent study 
reported a 0% rate of intestinal dehiscence following full-thickness surgical 
intestinal biopsy in both dogs and cats (Mitterman and others 2016). Proposed 
risk factors for dehiscence following gastrointestinal surgery in dogs include 
preoperative peritonitis, preoperative hypoalbuminaemia and intra-operative 
hypotension, although findings are often conflicting (Harvey 1990, Allen and 
others 1992, Ralphs and others 2003, Grimes and others 2011, Snowdon and 
others 2016). One study concluded that dogs and cats undergoing more than one 
intestinal surgical procedure were less likely to survive (Wylie and Hosgood 
1994). This finding, combined with the proposal of intra-operative hypotension 
as a possible risk factor for dehiscence, suggests that undertaking multiple 
surgical procedures under a protracted general anaesthetic may increase the risk 
of complications such as dehiscence. A study investigating risk factors for 
dehiscence of stapled enterectomy in dogs reported a greater odds of dehiscence 
in anastomoses involving the large intestine, although case numbers were small 
(Snowdon and others 2016). Neoplasia is a catabolic state and may have an effect 
on anabolic processes such as tissue healing. This raises the possibility of an 
increased risk of dehiscence when a full-thickness incision is made in the 
intestinal tract in the presence of neoplasia. However, there is no evidence to 
date that suggests the presence of neoplasia influences intestinal healing in 
veterinary medicine (Smith and others 2011). 
 
The primary aim of this study was to document the incidence of surgical site 
dehiscence after full-thickness gastrointestinal biopsy in a large population of 
dogs and cats. The second aim was to investigate the association between the 
following pre-specified risk factors and dehiscence: low pre-operative serum 
albumin, biopsy through neoplastic tissue, biopsy alongside another major 
abdominal surgical procedure and biopsy of the colon. 
 
Materials and Methods 
 
Clinical data from 12 UK-based small animal referral hospitals (both private and 
university) were collected from the study period (January 2004 to December 
2014). The data were anonymously reviewed. Ethical approval was obtained 
from an institutional ethics committee prior to data collection. 
A data table template was submitted to each institution along with explanatory 
guidelines for completion. Inclusion criteria were all dogs and cats undergoing 
full-thickness gastrointestinal biopsy during the study period, with sufficient 
clinical records to complete the data table and a minimum of 14 days clinical 
follow up. Dogs and cats were excluded from the study if they had pre-existing 
septic peritonitis (see definition below). Information obtained from the clinical 
records of each case included case identification, signalment, pre-operative 
serum albumin concentration (including reference ranges), date of 
gastrointestinal biopsy, location and number of gastrointestinal biopsies, 
histopathological diagnosis and documentation of any abdominal surgical 
procedures performed under the same general anaesthetic as the 
gastrointestinal biopsies. Post-operative complications were recorded as a free-
text description. If post-operative gastrointestinal dehiscence occurred then the 
timing, method of diagnosis and identified cause were recorded where known. 
Once completed, the data table from each centre was submitted to an 
administrator, who was not involved in data analysis. Each centre was 
anonymised via a simple coding system known only to the administrator. The 
coded data were then forwarded for analysis. 
 
The complications data were used to determine the two outcome measures used, 
namely whether dehiscence (definite dehiscence yes/no), or patient death from 
any cause (dead yes/no), had occurred within 14 days of the procedure. For 
cases for which it was not possible to confirm that dehiscence had occurred but 
clinical records and outcome suggested it was possible, a third category of 
possible dehiscence was used. 
 
For the purpose of data analysis, the following definitions were determined prior 
to data collection. A ‘low pre-operative serum albumin’ was defined as any value 
lower than one standard deviation below the lower limit of the reference 
interval. An overall diagnosis of neoplasia was assigned to an individual case if 
the histopathology report concluded a diagnosis of neoplasia from one or more 
of the gastrointestinal biopsy sites. Additional abdominal surgical procedures 
performed under the same general anaesthetic as the gastrointestinal biopsy 
were classified as minor (biopsy of an intra-abdominal organ e.g. liver, pancreas, 
mesenteric lymph node, or placement of an oesophageal feeding tube) or major 
(all other abdominal surgery e.g. enterectomy, cholecystectomy, liver lobectomy, 
gastrostomy tube placement). A case was deemed to have definite post-operative 
gastrointestinal dehiscence and associated septic peritonitis by one or more of 
the following methods: identification of intracellular bacteria on cytological 
assessment of peritoneal fluid, positive bacterial culture from peritoneal fluid, 
consistent gross findings at revision surgery and/ or post mortem confirmation. 
A case was deemed to have possible post-operative gastrointestinal dehiscence 
and associated septic peritonitis if this was suspected based on review of the 
submitted clinical information but was neither confirmed, nor excluded, by any 
of the methods listed above. The term suspected dehiscence included all cases of 
definite and possible dehiscence. 
 
 Initial analysis related the various explanatory variables to the outcome of 
“definite dehiscence”, and ‘dead within 14 days’. Secondary analysis related these 
variables to the outcome “suspected (definite or possible) dehiscence”.  
 
Statistical analysis 
The statistical analysis was pre-planned to examine the relationship between the 
outcome measures and four risk factors (low pre-operative serum albumin, 
concomitant neoplasia, an additional major abdominal surgical procedure and 
colonic biopsy) using multivariable logistic regression. According to 
conventional calculations (Vittinghoff and McCulloch 2007) this would require, 
at the very least, 40 complications (outcome measures) and, assuming a similar 
incidence of dehiscence as previous studies (see above), imply the need to collect 
about 400 cases. 
 
In this study we found a lower rate of dehiscence than predicted and so 
exploratory analysis was carried out using univariable logistic regression with 
odds ratios and 95% confidence intervals calculated for various putative risk 
factors. 
  
Results 
 
Cats 
 
One hundred and seventy two cats from 12 submitting institutions met the 
inclusion criteria. Age at the time of gastrointestinal biopsy was available for 166 
cats; median age was 105.8 months (range 6.4 months to 240.7 months). There 
were 3 entire male cats, 3 entire female cats, 104 neutered male cats and 62 
neutered female cats. There were 103 domestic shorthair cats, 10 domestic 
longhair cats, 9 Siamese cats, 8 Persian cats, 7 Bengal cats, 7 Burmese cats, 6 
Ragdoll cats, 6 Maine coon cats, 4 British shorthair cats, 4 Oriental cats, 3 Birman 
cats and one each of a number of other breeds (Balinese, Egyptian mau, Exotic 
shorthair, Havana brown and unknown). 
 
The number of gastrointestinal biopsies performed is shown in Table 1a. A pre-
operative serum albumin concentration was available for 163 cats and was low 
in 17 (10.4%). Histopathological analysis was available for 170 cats; neoplasia 
was diagnosed at one or more sites in 30 (17.6%). Information regarding 
concurrent abdominal surgical procedures was available for 164 cats; of these, 
42 (25.6%) had another major abdominal procedure performed at the same time 
as gastrointestinal biopsy. 
 
Of the 172 cats in the study, 2 (1.2%) had definite dehiscence of a 
gastrointestinal biopsy site, corresponding to odds of 0.012 (95%CI: 0.003-
0.047). Dehiscence was excluded definitively in 166 cats (96.5%). The remaining 
4 cats had insufficient detail in the clinical record to definitively rule out 
dehiscence and were therefore classed as having possible dehiscence; 3 
deteriorated in the post-operative period and were euthanised as a result and 1 
died suddenly 3 days post-operatively. Investigation into the cause of the post-
operative deterioration in these cases was either not performed or not reported, 
and therefore the possibility of dehiscence could not be definitively excluded. 
 
For the 2 cats with definite dehiscence, both had a low pre-operative serum 
albumin concentration and neither had an additional major surgical procedure 
performed under the same general anaesthetic. One cat was diagnosed with 
definite dehiscence of multiple gastrointestinal biopsy sites at post mortem 
examination 7 days post-operatively; the cause of the dehiscence was recorded 
as unknown. This cat had a single biopsy taken from each of the stomach, 
jejunum and colon and did not have a diagnosis of neoplasia. The second cat with 
definite dehiscence was diagnosed with septic peritonitis 2 days after a single 
jejunal biopsy, based on cytological/ bacteriological testing. Information relating 
to the site and reason for dehiscence were not available for this cat and a 
histopathological diagnosis of intestinal lymphoma was made from the biopsy. 
Both of the cats with definite dehiscence were dead at 14 days post-operatively. 
 
One hundred and fifty four cats (89.5%) were alive at 14 days post-operatively. 
Of the 18 cats that were not alive, 14 were euthanised (77.8%) and 4 died (Table 
1b). Eight cats were euthanised because of a perceived poor prognosis 
associated with the histopathology result and the remaining 6 cats because of a 
poor post-operative recovery. Details relating to the post-operative recovery and 
timing of euthanasia were infrequently reported. 
 
The planned statistical analysis was inappropriate because of infrequent 
dehiscence. Only 2 definite dehiscence events were reported and both of these 
were in cats with low pre-operative serum albumin concentrations, meaning that 
logistic regression or calculation of odds ratios on this end point were not 
feasible (Table 1c). An exploratory Fisher’s exact test suggests that low albumin 
was significantly associated with dehiscence (p=0.01).   
 
The incidence of suspected dehiscence, 6/172, was also low (3.5%) but allowed 
more statistical exploration. Four of the six cats had low albumin, so that the 
odds ratio for suspected dehiscence in cats with low albumin was 22.2 (95% CI: 
3.7-132.7); the wide confidence interval resulting from the small number of 
‘events’ recorded and consequent poor precision. There seemed to be little risk 
of suspected dehiscence associated with any of the other pre-specified variables 
(Table 1d), although the power of all these analyses was extremely low.  
 
The final outcome that was explored was death within the first 14 days post-
operatively (Table 1e). A total of 18 cats were dead within two weeks of surgery, 
as a result of having died (n=4), euthanasia due to poor post-operative recovery 
(n=6) or euthanasia based on the prognosis following histopathology (n=8). 
There was some evidence to suggest that a low pre-operative serum albumin 
concentration was associated with death. Seven of 17 cats that had low albumin 
concentration, whereas only 10 of 146 cats with normal albumin concentration 
were dead within 14 days – an odds ratio of 9.52 (95%CI: 2.98-30.36). . A 
histopathological diagnosis of neoplasia was also associated with death within 
the first 14 days post-operatively, with univariable analysis, odds ratio of 4.73 
(95%CI: 1.68-13.29). Despite the larger number of events (deaths) in these 
analyses, the precision in calculation of odds ratios is low. 
 
Dogs 
 
One hundred and ninety-five dogs from 12 submitting institutions met the 
inclusion criteria. Age at the time of gastrointestinal biopsy was available for 193 
dogs; median age was 77.1 months (range 0.2 months to 180.5 months). There 
were 42 entire male dogs, 19 entire female dogs, 64 neutered male dogs and 70 
neutered female dogs. There were 25 Labrador retrievers, 20 cross-breeds, 12 
German shepherd dogs, 10 boxers, 10 English springer spaniels, 9 cocker 
spaniels, 7 Border collies, 7 Jack Russell terriers, 6 Cavalier King Charles 
spaniels, 6 Dachshunds, 6 Rottweilers, 6 Staffordshire bull terriers, 5 golden 
retrievers, 5 Weimaraners, 5 West Highland white terriers, 4 Miniature 
schnauzers, 3 Dalmatians, 3 Irish setters, 3 Lhasa apso, 2 Border terriers, 2 bull 
mastiff, 2 Dobermanns, 2 French bulldogs, 2 Great Danes, 2 lurchers, 2 Shih tzus, 
2 whippets and one each of a number of other breeds (Basset bleu de gascogne, 
Bedlington terrier, Bernese mountain dog, bichon frise, Bloodhound, Bouvier des 
Flandres, chow chow, English bulldog, English bull terrier, flat coated retriever, 
Fox terrier, German shorthaired pointer, greyhound, Hungarian vizsla, keeshond, 
leonberger, Maltese terrier, Newfoundland, Norwich terrier, Old English 
sheepdog, Scottish terrier, Shar pei, Shetland sheepdog, Siberian husky, Skye 
terrier, standard poodle, St. Bernard). 
 
The number of gastrointestinal biopsies performed is shown in Table 2a. A pre-
operative serum albumin concentration was available for 171 dogs and was low 
in 53 (31.0%). Histopathological analysis was available for all 195 dogs; 
neoplasia was diagnosed at one or more sites in 24 (12.3%). Information 
regarding concurrent surgical procedures was available for 168 dogs; of these, 
81 (48.2%) had another major abdominal surgical procedure performed at the 
same time as gastrointestinal biopsy. 
 
Of the 195 dogs in the study, 2 (1.0%) had definite dehiscence of a 
gastrointestinal biopsy site, corresponding to odds of 0.010 (95%CI: 0.003-
0.042). Dehiscence was excluded definitively in 190 dogs (97.4%). The 
remaining 3 dogs had insufficient detail in the clinical record to definitively rule 
out dehiscence and were therefore classed as having possible dehiscence; 2 died 
3 days post-operatively and 1 suffered cardiopulmonary arrest in the post-
operative period (timing not reported) and was successfully resuscitated. 
Investigation into the cause of the post-operative deterioration in these cases 
was either not performed or not reported, and therefore the possibility of 
dehiscence could not be definitively excluded. Five dogs (2.6%) were classified 
as having suspected dehiscence. 
 
Neither of the two dogs with definite dehiscence had a low pre-operative serum 
albumin concentration, colonic biopsy, final diagnosis of neoplasia or additional 
major abdominal surgical procedure performed under the same general 
anaesthetic. One dog was diagnosed with definite dehiscence of the jejunal 
biopsy site at repeat surgery 1 day post-operatively. This dog had a single biopsy 
taken from each of the duodenum, jejunum and ileum. Iatrogenic damage to the 
mesenteric border at the jejunal biopsy site was reported at the first surgery, 
which was repaired. It was this repair of the mesenteric border that dehisced 
rather than the anti-mesenteric biopsy site. This dog was euthanised due to a 
poor recovery from a third surgery to address a second episode of septic 
peritonitis. The second dog with definite dehiscence was diagnosed with septic 
peritonitis 3 days after a single biopsy taken from each of the stomach, 
duodenum, jejunum and ileum, based on cytological and/ or bacteriological 
testing. Information relating to the site and reason for dehiscence, or 
management following the diagnosis of septic peritonitis, were not available for 
this dog although it was alive at 14 days post-operatively. 
 
One hundred and eighty four dogs (94.4%) were alive at 14 days post-
operatively. Of the 11 dogs that were not alive, 5 were euthanised (45.5%) and 6 
died (Table 2b). The reason for euthanasia in all five dogs was a poor post-
operative recovery and not because of perceived poor prognosis associated with 
the histopathology result. Details of the post-operative recovery and the timing 
of euthanasia were infrequently reported. 
 
The planned statistical analysis was inappropriate because neither of the definite 
dehiscence dogs had a low pre-operative serum albumin concentration, colonic 
biopsy, diagnosis of neoplasia nor an additional major abdominal surgical 
procedure performed (Table 2c).  The incidence of suspected dehiscence, 5/195, 
was also low (2.6%) and there was no association between this and any of the 
putative risk factors investigated. 
 
The final outcome that was explored was death within the first 14 days post-
operatively and again, there was no apparent association of this outcome with 
any of the four investigated variables. 
 
Discussion 
 
This study reports a low incidence of definite dehiscence following full-thickness 
gastrointestinal biopsy in dogs (1%) and cats (1.2%). These findings are 
comparable to the 0% incidence of dehiscence following full-thickness 
gastrointestinal surgery previously reported in cats (Ralphs and others 2003, 
Smith and others 2011) and notably lower than has previously been reported for 
dogs (Shales and others 2005). The incidence of suspected dehiscence (2.6% in 
dogs and 3.5% in cats) takes into account the cases in which dehiscence could 
not be definitively excluded based on the submitted data and may include cases 
that did not dehisce, leading to a possible over-estimate. 
 
It is paramount that the potential benefits of an invasive procedure such as 
surgical gastrointestinal biopsy, with possibly life-threatening associated 
complications, are scrutinised closely when a less invasive technique is available. 
If analysis of endoscopic gastrointestinal biopsy samples were to consistently 
provide an accurate diagnosis then it would not be possible to justify a surgical 
technique to obtain the same information. 
However, the histopathological distinction between an inflammatory 
enteropathy and neoplasia can be challenging. For example, attempting to 
differentiate between chronic inflammation (e.g. inflammatory bowel disease) 
and small cell lymphoma in cats is notoriously difficult (Willard and others 
2010). A key histologic feature used to differentiate feline intestinal lymphoma 
from inflammatory bowel disease is lymphoid infiltration beyond the mucosa in 
lymphoma (Kiupel 2010).  The need to obtain a biopsy sample that includes 
intestinal wall deep to the mucosa implies the need to collect a full-thickness 
surgical biopsy. On the other hand, techniques such as immunophenotyping and 
PCR to determine clonality of infiltrating lymphocytes may allow accurate 
differentiation between intestinal lymphoma and inflammation on endoscopic 
mucosal biopsy samples in dogs and cats (Kiupel 2010, Carrasco and others 
2015). Even so, although biopsies of the gastric and duodenal mucosa are readily 
obtained endoscopically access to the ileum requires lower gastrointestinal 
endoscopy, with the need for appropriate colonic preparation pre-sampling, and 
the jejunum is not accessible via this approach. Poor agreement between 
endoscopic biopsies from the duodenum and ileum has been shown when 
attempting to distinguish feline inflammatory bowel disease and alimentary 
lymphoma and a diagnosis of lymphoma could only be found by evaluation of 
ileal biopsies in a subset of cats. (Scott and others 2011). Similar discrepancies in 
histopathological diagnosis were also apparent when duodenal and ileal biopsies 
from dogs with enteropathy were compared (Casamian-Sorrosal and others 
2009). These studies highlight the importance of obtaining a biopsy from the 
ileum in order to maximize the likelihood of obtaining an accurate diagnosis and 
therefore support the use of a surgical biopsy technique if the required expertise 
are not available to obtain an endoscopic ileal biopsy. 
One study comparing endoscopic and surgical biopsy for the diagnosis of 
inflammatory bowel disease and alimentary lymphoma in cats concluded that 
endoscopic biopsy provided a diagnosis of lymphoma in only 3 of 10 cats 
confirmed to have lymphoma by surgical biopsy (Evans and others 2006). 
Endoscopic biopsies were not obtained from the ileum, although surgical 
biopsies were, therefore this study does not directly compare the biopsy 
techniques and the absence of endoscopic ileal biopsies is likely to account for 
the low detection of lymphoma with this technique. 
A further advantage of surgical biopsy via a midline coeliotomy is the 
opportunity to perform a thorough abdominal exploration and to sample any 
grossly abnormal tissue that may be identified, which can, for instance, be 
advantageous in investigation of chronic gastrointestinal disease in cats 
(Kleinschmidt and others 2010). Surgical biopsies can also be obtained without 
the need for specialist equipment meaning they are readily performed in general 
practice and consequently provide a means of reaching a diagnosis in cases 
which are not candidates for referral. It is worth noting that patients undergoing 
coeliotomy for another surgical technique (e.g. cholecystectomy, liver 
lobectomy) may have concurrent surgical gastrointestinal biopsy performed as it 
makes sense to obtain surgical biopsies rather than performing an additional 
endoscopic procedure. Any concerns regarding the post-operative recovery 
following coeliotomy may be obviated by performing laparoscopically-assisted 
intestinal biopsy however the intestinal dehiscence rate with such a technique is 
likely comparable to that when biopsies are obtained via coeliotomy as the 
intestinal surgical biopsy technique is identical for the two procedures 
(Mitterman and others 2017). 
 
Both definite and suspected dehiscence were associated with a low pre-operative 
serum albumin concentration in cats, although caution is required in 
interpreting this finding because of the low number of dehiscence events and 
consequent low study power. This finding is in contrast to some previous 
publications investigating the potential association between pre-operative 
serum albumin and incidence of gastrointestinal dehiscence in dogs and cats 
(Harvey 1990, Wylie and Hosgood 1994, Smith and others 2011). A possible 
reason for this discrepancy is the larger number of cases included in our study, 
permitting us to identify associations of lower magnitude of effect despite the 
low number of dehiscence events overall. The necessary role of proteins in 
wound healing is widely accepted but the exact contribution of, and necessity for, 
albumin is unknown. Low serum albumin may not necessarily be causative for 
impaired tissue healing, but rather associated with it. For example, cats and dogs 
that are systemically unwell may present with a reduced serum albumin 
concentration and have impaired tissue healing for other reasons such as poor 
tissue perfusion. None of the other proposed risk factors were associated with 
dehiscence in cats. With a low incidence of definite and suspected dehiscence, the 
power of the study was low meaning weak associations may not have been 
detected even if they did exist. On the other hand, unless an association is 
reasonably strong and can be detected in a dataset of this size it may suggest that 
it is not likely to be of great clinical importance.  
Cats with a low pre-operative albumin concentration were more likely to be 
dead at 14 days post-operatively than those with a normal albumin 
concentration. Those with a histopathological diagnosis of neoplasia were also 
more likely to be dead at 14 days post-operatively. The latter association is likely 
to be causative as a poor prognosis associated with the histopathological 
diagnosis was cited as the reason for euthanasia in 57.1% (8/14) of euthanised 
cats. This finding suggests that gastrointestinal biopsy may still be worthwhile 
even if treatment is not pursued, because obtaining a histopathological diagnosis 
may serve to guide owners’ decisions regarding management options. 
 
Neither definite nor suspected dehiscence was significantly associated with any of 
the risk factors investigated in dogs. Again, with a low incidence of definite 
dehiscence, the power of the study was low. 
Similarly, none of the proposed risk factors were associated with death by 14 
days post-operatively in dogs. Interestingly, a poor prognosis associated with the 
histopathological diagnosis was not cited as the reason for euthanasia in any of 
the 5 dogs that were euthanised, which is in contrast to the cats in the study. All 
dogs that were euthanised had a non-neoplastic histopathological diagnosis 
(enteritis or no abnormality detected) and were euthanised due to a poor post-
operative recovery. The data table submitted to the contributing institutions was 
designed to obtain information from the clinical records that enabled us to 
determine the principle outcome variables; was the case dead or alive at 14 days 
post-operatively and had a dehiscence event occurred (yes/no/ possibly). 
Obtaining a detailed account of case management and clinical progress in the 
post-operative period was beyond the scope of the table submitted and the aims 
of the study.  The absence of this information does limit further interpretation of 
the cases that died or were euthanised for reasons other than a poor prognosis 
associated with the histopathological diagnosis. 
 
The 1% incidence of definite dehiscence following full-thickness gastrointestinal 
biopsy in dogs is substantially lower than the 12% previously reported (Shales et 
al 2005). It is difficult to offer an explanation for this as both studies included 
cases operated solely by referral institutions and there were only two years 
between cessation of data collection for the study by Shales et al and the 
initiation of data collection for the current study, hence a temporal effect is 
considered unlikely. It is possible that the cases included in the study by Shales 
et al were either systemically unwell to a greater degree, or had co-morbidities, 
which posed them to be a greater anaesthetic and/ or surgical risk. It is 
challenging to objectively document the pre-operative stability of a patient and 
then accurately recall this information therefore directly comparing the two 
studies in this respect is not possible. None of the cases included in the study by 
Shales et al were reported to have pre-operative septic peritonitis, which was an 
exclusion criteria for the current study, thereby eliminating the possibility of 
inclusion of this subgroup of critical patients in the study reporting a 12% 
incidence of dehiscence. In the present study 25% of cats and 48% of dogs had 
another major abdominal surgical procedure performed at the same time as the 
gastrointestinal biopsies compared to 9% of the dogs reported by Shales et al. 
This difference suggests that the principal reason for surgery in the earlier paper 
was to obtain gastrointestinal biopsies for investigation of a chronic enteropathy 
whereas the concurrent major abdominal surgical procedure performed in a 
high percentage of the cases presented here was likely the primary indication for 
surgery and as such these patients may have been more likely to present with 
systemic illness and possibly posed a greater anaesthetic or surgical risk. This 
theory supports an expectation that cases undergoing a concurrent major 
abdominal surgical procedure may be less stable and therefore at increased risk 
of post-operative complications (e.g. dehiscence) which does not explain the 
different incidence of dehiscence reported by the two studies. 
 
A major limitation of this study is the retrospective nature of the data collection. 
Incomplete data submission meant it was not always possible to definitively 
determine if dehiscence had occurred or not. As previously stated, this led to an 
incidence of suspected dehiscence that might be an over-estimation of the actual 
incidence. On the other hand, retrospective data collection of this nature might 
also lead collaborators to omit cases that might be considered to ‘show them in a 
bad light’ and so there may be a suspicion of bias toward more optimistic 
outcomes, although anonymisation of data should help to minimize this effect. 
Also, our inclusion criteria will have inevitably led to the exclusion of some cases 
because of incomplete clinical records or inadequate length of follow up.  For 
instance, it could be that some cases that were not included were those that 
dehisced, and were subsequently managed by the referring practice without 
feedback to the referral centre where the initial biopsy procedure was 
performed and from where our data was derived. Such a series of events could 
lead to the reporting of an erroneously low incidence of dehiscence. 
Another factor that may have lead to under-estimation of the incidence of 
dehiscence is the potential impact of the 12 cats and 8 dogs that died or were 
euthanised within the first 14 days post-operatively but were not categorized as 
either definite or possible dehiscence. This subset of non-survivors either 
deteriorated post-operatively and subsequently died or were euthanised (cats 
n=5, dogs n=8), or they were euthanised on the basis of a poor prognosis 
associated with the histopathological diagnosis (cats n=7, dogs n=0). The early 
post-operative death or euthanasia of these cases means that they may not have 
survived for a sufficient period post-operatively for dehiscence to occur and be 
detected. Having said this, those cases euthanised on the basis of a 
histopathology result are likely to have been managed for several days post-
operatively whilst the tissue was analysed and therefore were likely alive during 
the high risk lag phase of intestinal healing. Unfortunately the exact timing of 
death or euthanasia in relation to the surgery date was rarely available and 
consequently more specific analysis was not possible. 
There was also a degree of assumption that a diagnosis of septic peritonitis 
equated to dehiscence of the gastrointestinal biopsy site; the latter only being 
definitively confirmed if either repeat surgery or post mortem examination was 
performed and this was the case in only two of four animals assigned to the 
definite dehiscence category. Although unlikely, other causes of septic peritonitis 
such as ascending infection from a peritoneal drain, intra-operative 
contamination or spontaneous bacterial peritonitis could not be eliminated as 
the cause of the peritonitis in the remaining two definite dehiscence cases. 
 
This study reports the incidence of surgical site dehiscence after full thickness 
gastrointestinal biopsy performed at referral hospitals in the UK. These results 
may not reflect the incidence of dehiscence after the same procedure is 
performed in general practice and it would be of interest to establish the 
incidence at non-referral UK hospitals over the same time period. It is assumed 
that the incidence of intestinal dehiscence reported in this study relates to 
surgical cases where an appropriate suture material and suture technique was 
used to close the intestinal biopsy site. Analysis of the suture material and suture 
technique used for the cases included was beyond the scope of this retrospective 
study and it is important to recognize that the dehiscence rate is likely to be 
considerably higher than that reported if the intestinal biopsy site is not closed 
appropriately. 
 
In conclusion, performing full-thickness gastrointestinal biopsy in dogs and cats 
can be considered a low risk procedure at referral hospitals in the UK although a 
definite dehiscence rate of 1% is not negligible given the high mortality rate 
associated with dehiscence. Consequently case selection should be carefully 
considered based on the potential merits of the procedure on an individual basis 
and the client should be adequately informed pre-operatively of the potential for 
life-threatening complications associated with surgical gastrointestinal biopsy. 
Although this study cannot provide absolute proof of an association it would be 
prudent to consider that in cats, a low pre-operative serum albumin 
concentration might increase the risk of dehiscence, or death by 14 days, and 
this risk should be factored into the decision-making process. Future prospective 
investigation in to the potential association between low pre-operative serum 
albumin and intestinal dehiscence risk should be considered. 
 
No conflicts of interest have been declared. 
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